Short- and long-term treatment with folic acid suppresses thrombus formation in atherogenic mice in vivo

Pathophysiology

Volumn 21, Issue 2, 2014, Pages 169-175

  Tamura, Yukinori ^a   Inoue, Ayumi ^b   Ijiri, Yoshinobu ^c   Naemura, Aki ^b   Yamamoto, Junichiro ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOBE GAKUIN UNIVERSITY   (Japan)

^c OSAKA SHOIN WOMEN'S UNIVERSITY   (Japan)

Author keywords

Atherothrombosis; Endothelial function; Folic acid; Platelet activation

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFICACY; ENDOTHELIUM; HELIUM NEON LASER; HYPERLIPOPROTEINEMIA TYPE 3; HYPOBETALIPOPROTEINEMIA; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PLATELET REACTIVITY; PRIORITY JOURNAL; THROMBOCYTE FUNCTION; THROMBOSIS; TREATMENT RESPONSE; VASODILATATION;

EID: 84903194629     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2014.04.001     Document Type: Article

References (36)

1. Freynhofer M.K., Bruno V., Wojta J., Huber K. The role of platelets in athero-thrombotic events. Curr. Pharm. Des. 2012, 18:5197-5214.
2. Salimi S., Naghavi A., Firoozrai M., Zand H., Tavilani H., Nakhaee A., Mohebbi A. Association of plasma nitric oxide concentration and endothelial nitric oxide synthase T-786C gene polymorphism in coronary artery disease. Pathophysiology 2012, 19:157-162.
3. Broderick T.L., Parrott C.R., Wang D., Jankowski M., Gutkowska J. Expression of cardiac GATA4 and downstream genes after exercise training in the db/db mouse. Pathophysiology 2012, 19:193-203.
4. Mohammadi M.T., Shid-Moosavi S.M., Dehghani G.A. Contribution of nitric oxide synthase (NOS) in blood-brain barrier disruption during acute focal cerebral ischemia in normal rat. Pathophysiology 2012, 19:13-20.
5. Donnelly J.G. Folic acid. Crit. Rev. Clin. Lab. Sci. 2001, 38:183-223.
6. Berry R.J., Li Z., Erickson J.D., Li S., Moore C.A., Wang H., Mulinare J., Zhao P., Wong L.Y., Gindler J., Hong S.X., Correa A. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N. Engl. J. Med. 1999, 341:1485-1490.
7. Bellamy M.F., McDowell I.F., Ramsey M.W., Brownlee M., Newcombe R.G., Lewis M.J. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. Eur. J. Clin. Invest. 1999, 29:659-662.
8. Chambers J.C., Ueland P.M., Obeid O.A., Wrigley J., Refsum H., Kooner J.S. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000, 102:2479-2483.
9. Chao C.L., Chien K.L., Lee Y.T. Effect of short-term vitamin (folic acid, vitamins B6 and B12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia. Am. J. Cardiol. 1999, 84:1359-1361. A1358.
10. Verhaar M.C., Wever R.M., Kastelein J.J., van Dam T., Koomans H.A., Rabelink T.J. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 1998, 97:237-241.
11. Verhaar M.C., Wever R.M., Kastelein J.J., van Loon D., Milstien S., Koomans H.A., Rabelink T.J. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial. Circulation 1999, 100:335-338.
12. Seto S.W., Lam T.Y., Or P.M., Lee W.Y., Au A.L., Poon C.C., Li R.W., Chan S.W., Yeung J.H., Leung G.P., Lee S.M., Ngai S.M., Kwan Y.W. Folic acid consumption reduces resistin level and restores blunted acetylcholine-induced aortic relaxation in obese/diabetic mice. J. Nutr. Biochem. 2010, 21:872-880.
13. Li M., Chen J., Li Y.S., Feng Y.B., Gu X., Shi C.Z. Folic acid reduces adhesion molecules VCAM-1 expression in aortic of rats with hyperhomocysteinemia. Int. J. Cardiol. 2006, 106:285-288.
14. Wang X., Qin X., Demirtas H., Li J., Mao G., Huo Y., Sun N., Liu L., Xu X. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007, 369:1876-1882.
15. Tawakol A., Migrino R.Q., Aziz K.S., Waitkowska J., Holmvang G., Alpert N.M., Muller J.E., Fischman A.J., Gewirtz H. High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease. J. Am. Coll. Cardiol. 2005, 45:1580-1584.
16. Shirodaria C., Antoniades C., Lee J., Jackson C.E., Robson M.D., Francis J.M., Moat S.J., Ratnatunga C., Pillai R., Refsum H., Neubauer S., Channon K.M. Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease. Circulation 2007, 115:2262-2270.
17. Ijiri Y., Miura M., Hashimoto M., Fukunaga C., Watanabe S., Kubota A., Oiwa K., Okuda T., Yamamoto J. A new model to evaluate the diet-induced prothrombotic state, using He-Ne laser-induced thrombogenesis in the carotid artery of apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Blood Coagul. Fibrinolysis 2002, 13:497-504.
18. Kovacs I.B., Tigyi-Sebes A., Trombitas K., Gorog P. Evans blue: an ideal energy-absorbing material to produce intravascular microinjury by He-Ne gas laser. Microvasc. Res. 1975, 10:107-124.
19. Naemura A., Mitani T., Ijiri Y., Tamura Y., Yamashita T., Okimura M., Yamamoto J. Anti-thrombotic effect of strawberries. Blood Coagul. Fibrinolysis 2005, 16:501-509.
20. Taka T., Ohta Y., Seki J., Giddings J.C., Yamamoto J. Impaired flow-mediated vasodilation in vivo and reduced shear-induced platelet reactivity in vitro in response to nitric oxide in prothrombotic, stroke-prone spontaneously hypertensive rats. Pathophysiol. Haemost. Thromb. 2002, 32:184-189.
21. Aoki R., Ikarugi H., Naemura A., Ijiri Y., Yamashita T., Yamamoto J. Endothelial dysfunction precedes atherosclerotic lesions and platelet activation in high fat diet-induced prothrombotic state. Thromb. Res. 2006, 117:529-535.
22. Tamura Y., Naemura A., Inoue A., Ijiri Y., Seki J., Yada T., Goto M., Shinohara M., Kawashima S., Giddings J.C., Yamamoto J. Impaired endothelial function may be due to decreased aortic tetrahydrobiopterin, assessed by a new flow-mediated vasodilation in vivo in hypercholesterolemic/atherogenic mice. Blood Coagul. Fibrinolysis 2009, 20:699-705.
23. Ratnatunga C.P., Edmondson S.F., Rees G.M., Kovacs I.B. High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation. Circulation 1992, 85:1077-1082.
24. Yamamoto J., Taka T., Nakajima S., Ueda M., Sugimoto E., Sasaki Y., Muraki T., Seki J., Watanabe S. A shear-induced in vitro platelet function test can assess clinically relevant anti-thrombotic effects. Platelets 1999, 10:178-184.
25. Jennings L.K. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb. Haemost. 2009, 102:248-257.
26. Lentz S.R. Mechanisms of homocysteine-induced atherothrombosis. J. Thromb. Haemost. 2005, 3:1646-1654.
27. Davis H.R., Lowe R.S., Neff D.R. Effects of ezetimibe on atherosclerosis in preclinical models. Atherosclerosis 2011, 215:266-278.
28. Ozaki M., Kawashima S., Yamashita T., Hirase T., Namiki M., Inoue N., Hirata K., Yasui H., Sakurai H., Yoshida Y., Masada M., Yokoyama M. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J. Clin. Invest. 2002, 110:331-340.
29. Halfon S., Malinowski J., Sinha U. Effect of anticoagulants and antiplatelet agents on platelet-mediated thrombin generation. Blood Coagul. Fibrinolysis 2002, 13:715-724.
30. Durand P., Prost M., Blache D. Folic acid deficiency enhances oral contraceptive-induced platelet hyperactivity. Arterioscler. Thromb. Vasc. Biol. 1997, 17:1939-1946.
31. Paul B., Whiting M.J., De Pasquale C.G., Mangoni A.A. Acute effects of 5-methyltetrahydrofolate on endothelial function and asymmetric dimethylarginine in patients with chronic heart failure. Nutr. Metab. Cardiovasc. Dis. 2010, 20:341-349.
32. Lonn E., Yusuf S., Arnold M.J., Sheridan P., Pogue J., Micks M., McQueen M.J., Probstfield J., Fodor G., Held C., Genest J. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 2006, 354:1567-1577.
33. Doshi S., McDowell I., Moat S., Lewis M., Goodfellow J. Folate improves endothelial function in patients with coronary heart disease. Clin. Chem. Lab. Med. 2003, 41:1505-1512.
34. Moens A.L., Claeys M.J., Wuyts F.L., Goovaerts I., Van Hertbruggen E., Wendelen L.C., Van Hoof V.O., Vrints C.J. Effect of folic acid on endothelial function following acute myocardial infarction. Am. J. Cardiol. 2007, 99:476-481.
35. Tello-Montoliu A., Jover E., Rivera J., Valdes M., Angiolillo D.J., Marin F. New perspectives in antiplatelet therapy. Curr. Med. Chem. 2012, 19:406-427.
36. Armitage J.M., Bowman L., Clarke R.J., Wallendszus K., Bulbulia R., Rahimi K., Haynes R., Parish S., Sleight P., Peto R., Collins R. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 2010, 303:2486-2494.